Učitavanje...
Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta
The development of and research into new therapies that can selectively and effectively destroy tumor cells that overexpress the ErbB2 receptor is a pressing task. Recently, research into the use of type I interferons in the treatment of cancer has intensified. Cytokine therapy is aimed at activatin...
Spremljeno u:
| Izdano u: | Acta Naturae |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
A.I. Gordeyev
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7385087/ https://ncbi.nlm.nih.gov/pubmed/32742732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.32607/actanaturae.10903 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|